Paper17202201
The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema.
Knudsen LL and 3 others. Br J Ophthalmol, 2007. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema. Papers, record 17202201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17202201
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The North Jutland County Diabetic Retinopathy Study (NCDRS) 2. Non-ophthalmic parameters and clinically significant macular oedema.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Retinopathy | Major topic |
| Macular Edema | Major topic |
| Adolescent | |
| Adult | |
| Albuminuria | |
| Blood Pressure | |
| Cross-Sectional Studies | |
| Denmark | |
| Diabetic Neuropathies | |
| Glycated Hemoglobin | |
| Humans | |
| Mass Screening | |
| Prevalence | |
| Risk Factors | |
| Severity of Illness Index | |
| Time Factors |
Source PubMed
References8
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15232600 | Epidemiology of diabetic retinopathy and macular oedema: a systematic review. | Eye (Lond) | 2004 | https://conductscience.org/library/papers/15232600 | PubMed |
| 2 | 6521986 | The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. | Ophthalmology | 1984 | https://conductscience.org/library/papers/6521986 | PubMed |
| 3 | 2988264 | Ocular complications in insulin treated diabetes mellitus. An epidemiological study. | Acta Ophthalmol Suppl (1985) | 1985 | https://conductscience.org/library/papers/2988264 | PubMed |
| 4 | 16825278 | The North Jutland County Diabetic Retinopathy Study: population characteristics. | Br J Ophthalmol | 2006 | https://conductscience.org/library/papers/16825278 | PubMed |
| 5 | 2587045 | The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. | Ophthalmology | 1989 | https://conductscience.org/library/papers/2587045 | PubMed |
| 6 | 8366922 | The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. | N Engl J Med | 1993 | https://conductscience.org/library/papers/8366922 | PubMed |
| 7 | 7826293 | The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. | Arch Ophthalmol | 1995 | https://conductscience.org/library/papers/7826293 | PubMed |
| 8 | 2866759 | Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. | Arch Ophthalmol | 1985 | https://conductscience.org/library/papers/2866759 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31637196 | Association of urinary albumin excretion with central foveal thickness and intravitreal conbercept treatment frequency in patients with diabetic macular edema. | Int J Ophthalmol | 2019 | https://conductscience.org/library/papers/31637196 | PubMed |
| 30679285 | Profile of a population-based diabetic macular oedema study: the Liverpool Eye and Diabetes Study (Sydney). | BMJ Open | 2019 | https://conductscience.org/library/papers/30679285 | PubMed |
| 26177037 | Risk Factors for Retinopathy and DME in Type 2 Diabetes-Results from the German/Austrian DPV Database. | PLoS One | 2015 | https://conductscience.org/library/papers/26177037 | PubMed |
| 23626903 | Optimal treatment of diabetic retinopathy. | Ther Adv Endocrinol Metab | 2013 | https://conductscience.org/library/papers/23626903 | PubMed |
| 23457327 | Current treatments in diabetic macular oedema: systematic review and meta-analysis. | BMJ Open | 2013 | https://conductscience.org/library/papers/23457327 | PubMed |
| 22937513 | Risk factors for clinically significant macular edema in a multi-ethnics population with type 2 diabetes. | Int J Ophthalmol | 2012 | https://conductscience.org/library/papers/22937513 | PubMed |
| 22356289 | Ranibizumab: in diabetic macular oedema. | Drugs | 2012 | https://conductscience.org/library/papers/22356289 | PubMed |
| 20964459 | Current approaches to the management of diabetic retinopathy and diabetic macular oedema. | Drugs | 2010 | https://conductscience.org/library/papers/20964459 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/17202201
GET https://conductscience.org/api/papers/v1/17202201/authors